Pharmacoepidemiology and Risk Factors assessment of Metabolic Syndrome in Geriatric Patients Admitted at Tertiary Care Hospital – A Cross-Sectional study
DOI:
https://doi.org/10.56294/saludcyt20251757Keywords:
Geriatrics, Hyperglycaemia, Threat factors, Smoking, Metabolic syndromeAbstract
Introduction: Metabolic syndrome (Mets) is the major threat factor for morbidity and mortality in geriatric patients. Cardiovascular diseases are the major complications and early detection, proper treatment, management help to improve quality of life. So, this study is to evaluate the risk components, risk behaviors, use, and effects of drugs for metabolic syndrome in the geriatric population.
Methods: This was a prospective cross-sectional investigation done for a duration of 6 months. Totally, 340 both male and female patients of age above 65 were enrolled. Ethical approval was obtained from MIMS, Mandya. The south asian diagnostic criteria were used in our study. Details such as demographics, threat factors, diagnosis, lab values, past and present medical conditions, past and present medications were collected and subjected to statistical analysis.
Results: Among 340 patients, male patients (57%) are more admitted in hospital. Based on diagnostic criteria majority of patients having three components (67%). Major threat factors are smoking (OR=27.5), family history (OR=2) and alcohol consumption (OR=1.38). Metformin, amlodipine and atorvastatin were commonly using for the management of risk components. The ANOVA results was found to be 0.00 for hyperglycaemia and 0.007 for hypertension in relation to gender wise distribution.
Conclusion: Our study concludes that male patients were more suffering from metabolic syndrome. Both Modifable and non-modifable risk factors influencing the metabolic syndrome. Therapeutic efficacy of drugs are also depends on threat factors. So, Proper education, drug selection and healthy life style practices helps to prevent complications, improve drug efficacy and quality of life.
References
1. Tassew WC, Woldie SS, Zeleke AM. Metabolic syndrome among patients with cardiovascular disease in Africa: A systematic review and meta-analysis. Clinical Epidemiology and Global Health. 2024 Nov;30:101817.
2. Salma Mostafa Mohamed, Mostafa Abbas Shalaby, El-Shiekh RA, El-Banna HA, Shimaa Ramadan Emam, Bakr AF. Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chemistry Advances. 2023 Dec 1;3:100335–5.
3. Sundarakumar JS, Stezin A, Menesgere AL, Ravindranath V. Rural-urban and gender differences in metabolic syndrome in the aging population from southern India: Two parallel, prospective cohort studies. eClinicalMedicine [Internet]. 2022 May 1 [cited 2022 May 2];47. Available from: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00125-0/fulltext?msclkid=7aa527afc05d11ecac82d72ffd690797.
4. Peterseim CM, Jabbour K, Ashwini Kamath Mulki. Metabolic Syndrome: An Updated Review on Diagnosis and Treatment for Primary Care Clinicians. Journal of Primary Care & Community Health. 2024 Jan 1;15.
5. H Pavithra, Naik PR. Prevalence of Metabolic Syndrome and its Risk Factors among Adults in a Rural Area of Dakshina Kannada District. Indian Journal of Community Medicine [Internet]. 2023 Jan 1;48(6):861–6.
6. Pandit K, Goswami S, Ghosh S, Mukhopadhyay P, Chowdhury S. Metabolic syndrome in South Asians. Indian Journal of Endocrinology and Metabolism [Internet]. 2012 [cited 2019 Sep 5];16(1):44. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263197/.
7. Ambroselli D, Masciulli F, Romano E, Catanzaro G, Besharat ZM, Massari MC, et al. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food. Nutrients [Internet]. 2023 Jan 26;15(3):640. Available from: https://www.mdpi.com/2072-6643/15/3/640.
8. Roller‐Wirnsberger R, Thurner B, Pucher C, Lindner S, Wirnsberger GH. The Clinical and Therapeutic Challenge of Treating Older Patients in Clinical Practice. British Journal of Clinical Pharmacology [Internet]. 2019 Aug 6;86(10):1904–11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495268/.
9. Peterseim CM, Jabbour K, Ashwini Kamath Mulki. Metabolic Syndrome: An Updated Review on Diagnosis and Treatment for Primary Care Clinicians. Journal of Primary Care & Community Health. 2024 Jan 1;15.
10. Upadhyay S, Shrivastava S, Kumar D, Atul Kabra, Uttam Singh Baghel. PHARMACOEPIDEMIOLOGY: A REVIEW. Asian Journal of Pharmaceutical Research and Development [Internet]. 2019 Apr 14 [cited 2025 May 31];7(2):83–7. Available from: https://ajprd.com/index.php/journal/article/view/464.
11. Kim KS, Kim SK, Sung KM, Cho YW, Park SW. Management of Type 2 Diabetes Mellitus in Older Adults. Diabetes & Metabolism Journal [Internet]. 2012;36(5):336. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486979/.
12. Benetos A, Petrovic M, Strandberg T. Hypertension Management in Older and Frail Older Patients. Circulation Research [Internet]. 2019 Mar 28;124(7):1045–60.
13. Hong S, Li QC, Jun X. Treatment of dyslipidemia in the elderly. Journal of Geriatric Cardiology. 2011 Apr 15;8(1):55–64.
14. Ondrej Zizka, Haluzik M, Jude EB. Pharmacological Treatment of Obesity in Older Adults. Drugs & Aging. 2024 Nov 1;41(11):881–96.
15. Basu S, Thirunavukarasu AJ, Maheshwari V, Zode M, Hassan R. Burden, determinants and treatment status of metabolic syndrome among older adults in India: a nationally representative, community-based cross-sectional survey. BMJ Public Health [Internet]. 2023 Nov 20 [cited 2024 Jul 24];1(1). Available from: https://bmjpublichealth.bmj.com/content/1/1/e000389.
16. Kaur J. A Comprehensive Review on Metabolic Syndrome. Cardiology Research and Practice. 2014;2014(1):1–21.
17. Rus M, Crisan S, Andronie-Cioara FL, Indries M, Marian P, Pobirci OL, et al. Prevalence and Risk Factors of Metabolic Syndrome: A Prospective Study on Cardiovascular Health. Medicina [Internet]. 2023 Sep 25;59(10):1711. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608643/.
18. Feinkohl I, Janke J, Hadzidiakos D, Slooter A, Winterer G, Spies C, et al. Associations of the metabolic syndrome and its components with cognitive impairment in older adults. BMC Geriatrics. 2019 Mar 7;19(1).
19. Kyung Wook Kang, Kim MK, Nam T, Kyung Ho Kang, Park WJ, Moon HS, et al. Association Between Sleep and the Metabolic Syndrome Differs Depending on Age. Journal of Korean Sleep Research Society. 1970 Jan 1;20(1):19–27.
20. Liu D, Xu ZX, Liu X, Yang HL, Wang L, Li Y. Education and metabolic syndrome: a Mendelian randomization study. Frontiers in Nutrition. 2024 Oct 31;11.
21. Laudisio A, Bandinelli S, Gemma A, Ferrucci L, Incalzi RA. Metabolic syndrome and functional ability in older age: the InCHIANTI study. Clinical nutrition (Edinburgh, Scotland) [Internet]. 2014 Aug;33(4):626–33. Available from: https://pubmed.ncbi.nlm.nih.gov/24035348/.
22. Hoveling LA, Liefbroer AC, Bültmann U, Smidt N. Understanding socioeconomic differences in metabolic syndrome remission among adults: what is the mediating role of health Behaviors. International Journal of Behavioral Nutrition and Physical Activity. 2021 Nov 9;18(1).
23. Shaimol, Anilasree B.P, Nahja Rosy K.E, Minhaj Alavi, Najwa Usman Uruniyan paramban and Mohamed Sameer et.al. Individualization of oral hypoglycemic agents in geriatric diabetic patients. World Journal of Pharmaceutical and Life Sciences 2022 Oct 6;8(11):96-105.
24. Mohd AH, Mateti UV, Venkateswarlu Konuru, Parmar MY, Kunduru BR. A study on prescribing patterns of antihypertensives in geriatric patients. Perspectives in clinical research. 2012 Jan 1;3(4):139–9.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Vishwas A T L, Ritesh Agrawal (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
